Press Releases from TolerogenixX GmbH (1 total)
TolerogenixX Reports Positive Phase Ib Data of its Lead Product to Combat Transp …
- Product shows excellent safety and tolerability
- Enables long-term reduction of standard medications and side effects while maintaining immune tolerance and transplant function
- Findings endorsed…
Go To Page:
